Anpario plc (LON:ANP - Get Free Report)'s stock price shot up 16.1% during mid-day trading on Wednesday . The company traded as high as GBX 498.80 ($6.76) and last traded at GBX 490.60 ($6.65). 119,891 shares were traded during trading, an increase of 205% from the average session volume of 39,261 shares. The stock had previously closed at GBX 422.50 ($5.73).
Wall Street Analysts Forecast Growth
Separately, Shore Capital reiterated a "house stock" rating on shares of Anpario in a research note on Wednesday, September 10th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Anpario presently has a consensus rating of "Buy" and a consensus price target of GBX 435.
Check Out Our Latest Report on Anpario
Anpario Price Performance
The stock has a fifty day moving average of GBX 408.39 and a 200-day moving average of GBX 413.44. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of £83.37 million, a price-to-earnings ratio of 2,014.74 and a beta of 0.58.
Anpario (LON:ANP - Get Free Report) last announced its quarterly earnings results on Wednesday, September 10th. The company reported GBX 16.87 earnings per share (EPS) for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. On average, equities research analysts predict that Anpario plc will post 23.5757801 EPS for the current fiscal year.
About Anpario
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.